Optimization of a methamphetamine conjugate vaccine for antibody production in mice

Por Stevens, Misty W., Gunnell, Melinda G., Tawney, Rachel, Owens, S. Michael
Publicado no Int Immunopharmacol (2016)

First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers

Por Stevens, Misty W, Henry, Ralph L, Owens, S Michael, Schutz, Ralph, Gentry, W Brooks
Publicado no MAbs (2014)

Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use

Por Stevens, Misty W, Stevens, Misty W, Stevens, Misty W, Stevens, Misty W, Tawney, Rachel L, Tawney, Rachel L, Tawney, Rachel L, Tawney, Rachel L, West, C Michael, West, C Michael, West, C Michael, West, C Michael, Kight, Alicia D, Kight, Alicia D, Kight, Alicia D, Kight, Alicia D, Henry, Ralph L, Henry, Ralph L, Henry, Ralph L, Henry, Ralph L, Owens, S Michael, Owens, S Michael, Owens, S Michael, Owens, S Michael, Gentry, W Brooks, Gentry, W Brooks, Gentry, W Brooks, Gentry, W Brooks
Publicado em 2014

Pharmacological effects of two anti-methamphetamine monoclonal antibodies: Supporting data for lead candidate selection for clinical development

Por Laurenzana, Elizabeth M, Stevens, Misty W, Frank, John C, Hambuchen, Michael D, Hendrickson, Howard P, White, Sarah J, Williams, D Keith, Owens, S Michael, Gentry, W Brooks
Publicado no Hum Vaccin Immunother (2014)